Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

AIMS: To determine the effects of empagliflozin on adiposity indices among patients with type 2 diabetes mellitus. METHODS: Changes in weight, waist circumference, estimated total body fat, index of central obesity and visceral adiposity index were assessed using analysis of covariance and testing o...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diab Vasc Dis Res
Huvudupphovsmän: Neeland, Ian J, McGuire, Darren K, Chilton, Robert, Crowe, Susanne, Lund, Søren S, Woerle, Hans J, Broedl, Uli C, Johansen, Odd Erik
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2016
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768401/
https://ncbi.nlm.nih.gov/pubmed/26873905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164115616901
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk